First Time Loading...

Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 9.18 USD 0.88% Market Closed
Updated: Apr 27, 2024

Phathom Pharmaceuticals Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Phathom Pharmaceuticals Inc
Cash from Operating Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Cash from Operating Activities
-$137.6m
CAGR 3-Years
-25%
CAGR 5-Years
-167%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Operating Activities
$22.8B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Operating Activities
$13.9B
CAGR 3-Years
0%
CAGR 5-Years
18%
CAGR 10-Years
15%
Pfizer Inc
NYSE:PFE
Cash from Operating Activities
$8.7B
CAGR 3-Years
-15%
CAGR 5-Years
-11%
CAGR 10-Years
-7%
Merck & Co Inc
NYSE:MRK
Cash from Operating Activities
$13B
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Cash from Operating Activities
$4.2B
CAGR 3-Years
-13%
CAGR 5-Years
-5%
CAGR 10-Years
-3%

See Also

What is Phathom Pharmaceuticals Inc's Cash from Operating Activities?
Cash from Operating Activities
-137.6m USD

Based on the financial report for Dec 31, 2023, Phathom Pharmaceuticals Inc's Cash from Operating Activities amounts to -137.6m USD.

What is Phathom Pharmaceuticals Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-167%

Over the last year, the Cash from Operating Activities growth was 6%. The average annual Cash from Operating Activities growth rates for Phathom Pharmaceuticals Inc have been -25% over the past three years , -167% over the past five years .